ArticleCase reports in oncology

Trastuzumab Deruxtecan for HER2-Positive Breast Cancer with Central Nervous System Metastasis.

Hiroaki Yamane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.